Old Web
English
Sign In
Acemap
>
authorDetail
>
Phillip Koo
Phillip Koo
Novartis
Medicine
Diabetes mellitus
Pharmacology
Pharmacokinetics
Anesthesia
3
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First‐in‐human clinical trial to assess pharmacokinetics, pharmacodynamics, safety and tolerability of iscalimab, an anti‐CD40 monoclonal antibody
2019
American Journal of Transplantation
Pascal Espie
Yan-Ling He
Phillip Koo
Denise Sickert
Cyrielle Dupuy
Edwige Chokote
Roland Schuler
Heidi Mergentaler
Jacinda Ristov
Julie Milojevic
Aurelie Verles
Andrea Groenewegen
Anita Auger
Alexandre Avrameas
Michael Rotte
Laurence Colin
Charles S. Tomek
Martha Hernandez‐Illas
James S Rush
Peter Gergely
Show All
Source
Cite
Save
Citations (23)
Assessment of pharmacokinetic drug-drug interaction between pradigastat and atazanavir or probenecid.
2016
The Journal of Clinical Pharmacology
Anisha E. Mendonza
Imad Hanna
Dan Meyers
Phillip Koo
Srikanth Neelakantham
Bing Zhu
Tapan K. Majumdar
Sam Rebello
Gangadhar Sunkara
Jin Chen
Show All
Source
Cite
Save
Citations (7)
Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects.
2015
European Journal of Clinical Pharmacology
Surya Ayalasomayajula
Dan Meyers
Phillip Koo
Atish Salunke
Tapan K. Majumdar
Sam Rebello
Gangadhar Sunkara
Jin Chen
Show All
Source
Cite
Save
Citations (3)
1